4-methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexenyl]-7a-
| Catalogue No. : |
C13635 |
| Product Name: |
4-methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexenyl]-7a- |
| Synonym: |
25-Hydroxyvitamin D2;Ercalcidiol; 25- |
| Chemical Name: |
3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3,25-diol;4-methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexenyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-cyclohexanol |
| CAS No. : |
21343-40-8 |
| Structure : |
|
| Molecular Formula: |
C28H44O2 |
| Molecular Weight: |
412.65 |
| Appearance: |
White solid |
| Solubility: |
Soluble in DMSO and in ethanol |
| Purity: |
>98% |
| Usage: |
25-Hydroxyvitamin D2 is used in serum to measure the concentration of vitamin D produced by the skin. It is known that 25-Hydroxyvitamin D2 can be detected in human serum using high-performance liquid chromatography and ultraviolet detection. Vitamin D2, known as ergocalciferol, is a fat soluble secosteroid which regulates neuromuscular function, reduces inflammation and controls cell proliferation, differentiation and apoptosis. Furthermore, 25-Hydroxyvitamin D2 can be converted into calcitriol, which can act as a local cytokine. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
